[Clinico-therapeutic considerations on some cases of subacute sclerosing panencephalitis].
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D000547:Amantadine / Q000627:therapeutic use; D000914:Antibodies, Viral / Q000032:analysis; D002648:Child; D004569:Electroencephalography; D006801:Humans; D007158:Immunologic Techniques; D007167:Immunotherapy; D007369:Interferon Inducers / Q000627:therapeutic use; D008459:Measles virus; D013344:Subacute Sclerosing Panencephalitis / Q000175:diagnosis / Q000188:drug therapy*
D000276:Adjuvants, Immunologic; D000305:Adrenal Cortex Hormones; D000914:Antibodies, Viral; D007369:Interferon Inducers; D000324:Adrenocorticotropic Hormone; D000547:Amantadine
Considerazioni clinico-terapeutiche su alcuni casi di panencefalite sclerosante subacuta.